CG
NEO icon

Cutler Group’s NeoGenomics NEO Stock Holding History

Cutler Group’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,700
Closed -$6K – 5303
2022
Q2 		$6K Buy
+1,700
New +$16.2K ﹤0.01% 3596
2022
Q1 		– Sell
-100
Closed -$1K – 5779
2021
Q4 		$1K Sell
100
-600
-86% -$23.5K ﹤0.01% 5065
2021
Q3 		$1K Hold
700
– – ﹤0.01% 5359
2021
Q2 		$1K Buy
700
+400
+133% +$17.7K ﹤0.01% 5358
2021
Q1 		$1K Buy
+300
New +$15.6K ﹤0.01% 5296
2020
Q4 		– Sell
-2,900
Closed -$1K – 5276
2020
Q3 		$1K Buy
+2,900
New +$108K ﹤0.01% 4396
2019
Q4 		– Sell
-1,600
Closed -$2K – 4388
2019
Q3 		$2K Buy
+1,600
New +$37.5K ﹤0.01% 3511

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cutler Group's NEO Position: Q3 2022 in Review

Cutler Group sold out of NeoGenomics (NEO) in Q3 2022, closing a stake of 2,478 shares — an estimated $20K sold.

Cutler Group first reported a position in NEO in Q2 2016 and held it in 12 quarters. The position peaked at $103K in Q1 2017. 245 funds tracked by Wall St. Rank hold NEO as of Q3 2022.

  • Cutler Group reported no remaining NeoGenomics position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 2,478 NeoGenomics shares in Q3 2022, an estimated $20K.
  • Cutler Group first reported a position in NeoGenomics in Q2 2016 and held it in 12 quarters.
  • Cutler Group's NeoGenomics position peaked at $103K in Q1 2017.
  • 245 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.